ASHP Publishes Seventeenth Edition of Popular Handbook on Injectable Drugs

Published Online: Wednesday, January 23, 2013
Follow Pharmacy_Times:
PRESS RELEASE

1/23/2013, BETHESDA, MD— The American Society of Health-System Pharmacists (ASHP) has published a new edition of its popular text, Handbook on Injectable Drugs, by Lawrence A. Trissel.

With a 35-year track record, the Handbook on Injectable Drugs is the premier reference for compatibility, stability, storage and preparation of parenteral drugs. The 17th edition is completely updated and peer reviewed with new monographs, new references, additional information and the latest guidelines.
 
As the industry’s “gold standard,” the 17th edition is uniquely designed to make complex and thorough data easily accessible to busy practitioners worldwide. The new edition includes a total of 332 monographs, all updated, including 23 fluids and 42 new references – a total of 2,830 in all, footnoted and linked.
 
The Handbook is now also available in a completely interactive format for computers, tablets, or smart phones. It presents the monographs in the same easy-to-read style and adds cutting-edge interactivity for customized search results in the blink of an eye. The search fields self-populate with drug names as users type.  In addition, quarterly updates will be sent out with revised and new monographs to subscribers of the Interactive Handbook for the most complete and up-to-date information.
 
For information, visit www.interactivehandbook.com. To order the single user Interactive Handbook, visit www.ashp.org/ihid. Institutional subscriptions are also available. Download the free app after purchasing your subscription by searching “ASHP iHID” in the App Store for Apple and Android devices.
 
To place orders for the book, ISBN: 978-1-58528-378-1, and view additional material, please visit www.ashp.org/hid17.  Or, please email custserv@ashp.org or call 1-866-279-0681 (US & Canada), 001-301-664-8700 (International).
 
To arrange an interview or book signing or to discuss co-marketing or bulk sales, please contact Rachel Gellman at rgellman@ashp.org

About the Author

Lawrence A. Trissel, B.S. Pharm., FASHP
Lawrence Trissel has served as director of clinical pharmaceutics research, Division of Pharmacy at the University of Texas, M.D. Anderson Cancer Center, where he managed the development and compounding of specialty investigational drug products. Trissel has also been the senior research products manager, Pharmaceutical Resources Branch, Developmental Therapeutics Program, Division of Cancer Treatment at the National Cancer Institute, within the National Institutes of Health.
 
Trissel is now an independent author and research consultant.  He is best known as the author of Handbook on Injectable Drugs, a core pharmacy reference work found in nearly every hospital and home care pharmacy in the United States and throughout the world.
Related Articles
Unless you personally know a residency director, it’s difficult to connect with one. That’s where pharmacy conferences come in.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today reported results for the third quarter ended Sept. 30, 2014. Net sales for the quarter were $1.2 billion and adjusted* diluted earnings per share were $0.74. (Adjusted* measures exclude specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles basis, third-quarter 2014 diluted earnings per share were $0.92.
Fifteen hospitals that use insulin pens will participate in ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety.
Latest Issues
$auto_registration$